A patient in New York has been infected with a strain of E. coli highly resistant to last-resort antibiotic treatments, according to an article on the Becker's Infection Control and Clinical Quality website.
This is the second U.S. patient with the untreatable superbug infection, following a Pennsylvania patient first made public last month.
The mcr-1 gene gives bacteria resistance to colistin, a last-line-of-defense antibiotic used to combat a number of resistant microorganisms.
Going into 2017, the White House has requested $1.1 billion be allocated to efforts to combat antibiotic resistance in the U.S.
Respecting EVS Workers: 19 Minutes Is Not Enough
Where are the Greenhouse Gas Emissions Hotspots in Healthcare?
Caravel Autism Health Opens Clinic in Lake Zurich, Illinois
The Future of Healthcare Facility Construction Projects
Ground Broken on Jupiter Medical Center's Second Hospital